Lipitor (AtorvaStatin) Lawsuit

Lipitor is a popular lipid-lowering pharmaceutical drug, that has the chemical name atorvastatin calcium, that was offered to the market in 1997. Lipitor quickly became one of the most popular statin drugs in the world. Similar to other pharmaceutical drugs, Lipitor contains side effects, primarily when first taking the drug that, that may include muscle pain fever and even jaundice.

While the labelled side effects are relatively benign to the user, and are negligible with respect their the use of statins in reducing cholesterol, there have bee much more serious cases of severe interactions whereby patients show signs of Type II diabetes.  Type II diabetes occurs when patients bodies’ fail to produce insulin thereby limiting the bodys ability to transport glucose and transform it into energy by cells.

In clinical trials, Lipitor has been shown to increase the risk of developing type 2 diabetes in patients.  This risk is particularly relevant to middle aged and older women. Clinical evidence from roughly 154,000 women report that those women who take Lipitor are 50% more likely to develop type 2 diabetes than those who did not take statin drugs. It is currently unknown what the particular mechanism is that demonstrates why older women in particular are at risk.  Medical professional and drug manufacturers have stated that the benefits of statin drugs greatly outweigh the risks of developing type 2 diabetes, even for older women.

With this medical research and the medical evidence women who have developed Type II diabetes while taking Lipitor have filed multiple lawsuits against the drugs manufacturer.  These patients allege that the drug caused them to develop type 2 diabetes and that this risk was not clearly stated in the literature and potentially by their doctor or pharmacist they received with their prescription and consuming the drug.